bone marrow transplantation

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

1 headnote for bone marrow transplantation

- Bone marrow transplantation

1.755 documents for bone marrow transplantation

- Maven Semantic: Bone Marrow Transplantation Research Database.
Search Over 47,000 People and Over 3,000 Research Organisations DUBLIN -- Maven Semantic (http://www.mavensemantic.com) announces updates to their Bo...
- Business Wire
- July 14, 2011
- Current legal intervention regarding 'experimental' treatments must be changed: an analysis of high doses of chemotherapy with autologous bone marrow transplantation for breast cancer patients.
I. INTRODUCTION A 35-year old woman, mother of three children, suffers from Stage IV metastatic breast cancer.(1) After finding a suspicious mass in...
- Journal of Law and Health
- Vol. 13 Nbr. 2, June 1998
- Grants and cooperative agreements; availability, etc.: Selective T cell depletion to improve bone marrow transplantation procedures; methods development,
- FR, March 12, 2001
- Notices
- National Institutes of Health

- Innovative Research Advances Stem Cell and Bone Marrow Transplantation
To: NATIONAL EDITORS Contact: Marina Carter, Fleishman-Hillard, +1-202-828-8878; marina.carter@fleishman.com, for the American Society of Hematology; or Laura Stark of the American Society of Hematology, +1-202-776- 0544; lstark@hematology.org; On site (12/7-12/11): +1-404-222-5705
- U.S. Newswire
- December 10, 2007
- Research Findings Underscore Needed Action to Safeguard Lungs of Young Cancer Survivors
St. Jude Children's Research Hospital investigators report long- term monitoring and education are needed to protect the lungs of high-risk patients after bone marrow transplantation MEMPHIS, Tenn., April 15 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital investigators have identified childhood cancer survivors who are at increased risk for deteriorating lung health, in part due to the lifesaving bone marrow transplants they underwent years earlier.
- U.S. Newswire
- April 15, 2010
- A review of the chemopreventative effects of oral retinoids for internal neoplasms.
... remission with chemoradiotherapy and bone marrow transplantation, relapse from minimal resid...
- Journal of Drugs in Dermatology
- Vol. 10 Nbr. 11, November 2011
- Renowned Bone Marrow Transplantation Expert Richard E. Champlin, M.D., Joins Gentium's Scientific Advisory Board.
VILLA GUARDIA (COMO), Italy -- Gentium S.p.A. (AMEX:GNT) (the "Company") announced today that Richard Champlin, M.D., has joined its Scientific Adviso...
- Business Wire
- September 15, 2005
- Congress Shouldn't Prohibit the Selling of Renewable Bone Marrow
How many things in our lives would we like to depend upon the generosity and selflessness of our fellow man, and do you think we would like the outcome? You say, "Williams, are you now putting down generosity and selflessness?" No, I'm not. Let me ask the question in a more direct way. Say you want a nice three-bedroom house. Which human motivation do you think would get you the house sooner: the generosity of builders or the builders' desire to earn some money? What about a nice car? Which motivation of auto companies and their workers do you trust will get you a car sooner: the generosity of owners and workers, or owner desire for profits and worker desire for wages? As for me, I put my faith in people's self-interest as the most reliable way to get them to do what I want, and I belie...
- Deseret News (Salt Lake City)
- November 25, 2009
- Pluristem Files Patent Application For PLX-1, Intended as an Innovative Stem Cell Solution For Improved Engraftment During Bone Marrow Transplantation.
HAIFA, Israel -- Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy company dedicated to the commercialization of stem cell products, today ann...
- Business Wire
- May 08, 2006
- Pluristem Initiates Pre-Clinical Study for PLX-1, an Innovative Stem Cell Solution for Improved Engraftment During Bone Marrow Transplantation.
HAIFA, Israel -- Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy company dedicated to the commercialization of stem cell products, today ann...
- Business Wire
- April 24, 2006